• Featured Product
  • KD/KO Validated

MCL1 Monoklonaler Antikörper

MCL1 Monoklonal Antikörper für WB, IHC, IF/ICC, Cytometric bead array, Indirect ELISA

Wirt / Isotyp

Maus / IgG2b

Getestete Reaktivität

human

Anwendung

WB, IHC, IF/ICC, Cytometric bead array, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

1E3C2

Kat-Nr. : 66026-1-PBS

Synonyme

1E3C2, Bcl2-L-3, Bcl-2-like protein 3, Bcl-2-related protein EAT/mcl1, EAT



Geprüfte Anwendungen

Produktinformation

66026-1-PBS bindet in WB, IHC, IF/ICC, Cytometric bead array, Indirect ELISA MCL1 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Maus / IgG2b
Klonalität Monoklonal
Typ Antikörper
Immunogen MCL1 fusion protein Ag10609
Vollständiger Name myeloid cell leukemia sequence 1 (BCL2-related)
Berechnetes Molekulargewicht 350 aa, 37 kDa
Beobachtetes Molekulargewicht35 kDa
GenBank-ZugangsnummerBC107735
Gene symbol MCL1
Gene ID (NCBI) 4170
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

MCL-1 is an anti-apoptotic member of the Bcl-2 family originally isolated from the ML-1 human myeloid leukemia cell line. Similar to BCL2 and BCL2L1, MCL1 can interact with BAX and/or BAK1 to inhibit mitochondria-mediated apoptosis. Mcl-1 is critical for the proliferation and survival of myeloma cells in vitro, and overexpression of Mcl-1 protein in myeloma cells is associated with relapse and short event-free survival in multiple myeloma patients. Recent studies show that MCL-1 is upregulated in numerous haematological and solid tumour malignancies. Therefore, MCL-1 has been suggested as a potential new therapeutic target.